No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Packaged Foods
Tecon Biology Co. Ltd. is a diversified agribusiness operating in China and globally, with key activities spanning animal nutrition, livestock, and financial services. The company's primary focus involves the research, development, manufacturing, and distribution of a comprehensive range of animal feed products, designed for various species including poultry, swine, ruminants, and aquatic life. Beyond specialized feeds, Tecon also produces essential protein feed components and edible oils sourced from soybeans, sunflowers, rapeseed, and cottonseeds. Its involvement in the livestock sector extends to pig breeding and rearing, as well as meat processing and sales. Additionally, the company is a producer and supplier of veterinary biological products. Expanding its portfolio, Tecon offers a variety of financial services, including loan and bill acceptance guarantees, trade and project financing, credit provisions, and supervision for commodity financing. Established in Urumqi, China, in 1993, the company adopted its current name, Tecon Biology Co.Ltd, in June 2016, having previously operated as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
www.tcsw.com.cnNo one on the platform currently holds 002100.SZ.
No tracked institution reports a position in 002100.SZ as of their last filing.
No one on the platform has traded 002100.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.8% | — | — | — | ||
| Rev. Growth % | -1.1% | 7.2% | ||||
| Profit Margin % | 1.2% | -1.0% | 4.1% | |||
| Free Cash Flow Margin % | 0.0% | -0.2% | -5.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $17.0B | +1.1% | $-0.19 | $-0.20–$-0.17 | — | 1 |
| 2027 | $19.2B | +13.0% | $0.62 | $0.30–$1.04 | — | 5 |
| 2028 | $20.2B | +5.5% | $0.66 | $0.59–$0.72 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $16.49 |
| -2.31% |
| $6.6B |
| — |
| 600186.SSLotus Health Group Company | $12.66 | -3.95% | $22.7B | — |
| 600305.SSJiangsu Hengshun Vinegar-Industry Co.,Ltd | $6.64 | -1.19% | $7.3B | — |
Source: Financial Modeling Prep · peers by sector/industry